Cargando…

Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy

Detalles Bibliográficos
Autores principales: Cardillo, Giuseppe, Mokhles, Sahar, Williams, Norman, Macbeth, Fergus, Russell, Christopher, Treasure, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705879/
https://www.ncbi.nlm.nih.gov/pubmed/26372699
http://dx.doi.org/10.1038/bjc.2015.331
_version_ 1782409095646543872
author Cardillo, Giuseppe
Mokhles, Sahar
Williams, Norman
Macbeth, Fergus
Russell, Christopher
Treasure, Tom
author_facet Cardillo, Giuseppe
Mokhles, Sahar
Williams, Norman
Macbeth, Fergus
Russell, Christopher
Treasure, Tom
author_sort Cardillo, Giuseppe
collection PubMed
description
format Online
Article
Text
id pubmed-4705879
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47058792016-01-27 Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy Cardillo, Giuseppe Mokhles, Sahar Williams, Norman Macbeth, Fergus Russell, Christopher Treasure, Tom Br J Cancer Letter to the Editor Nature Publishing Group 2015-12-01 2015-09-15 /pmc/articles/PMC4705879/ /pubmed/26372699 http://dx.doi.org/10.1038/bjc.2015.331 Text en Copyright © 2015 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Letter to the Editor
Cardillo, Giuseppe
Mokhles, Sahar
Williams, Norman
Macbeth, Fergus
Russell, Christopher
Treasure, Tom
Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
title Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
title_full Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
title_fullStr Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
title_full_unstemmed Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
title_short Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
title_sort comment on: ‘kras and braf mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705879/
https://www.ncbi.nlm.nih.gov/pubmed/26372699
http://dx.doi.org/10.1038/bjc.2015.331
work_keys_str_mv AT cardillogiuseppe commentonkrasandbrafmutationsareprognosticbiomarkersinpatientsundergoinglungmetastasectomyofcolorectalcancervariationinsurvivalassociatedwithprotooncongenesisnotevidenceforeffectivenessoflungmetastasectomy
AT mokhlessahar commentonkrasandbrafmutationsareprognosticbiomarkersinpatientsundergoinglungmetastasectomyofcolorectalcancervariationinsurvivalassociatedwithprotooncongenesisnotevidenceforeffectivenessoflungmetastasectomy
AT williamsnorman commentonkrasandbrafmutationsareprognosticbiomarkersinpatientsundergoinglungmetastasectomyofcolorectalcancervariationinsurvivalassociatedwithprotooncongenesisnotevidenceforeffectivenessoflungmetastasectomy
AT macbethfergus commentonkrasandbrafmutationsareprognosticbiomarkersinpatientsundergoinglungmetastasectomyofcolorectalcancervariationinsurvivalassociatedwithprotooncongenesisnotevidenceforeffectivenessoflungmetastasectomy
AT russellchristopher commentonkrasandbrafmutationsareprognosticbiomarkersinpatientsundergoinglungmetastasectomyofcolorectalcancervariationinsurvivalassociatedwithprotooncongenesisnotevidenceforeffectivenessoflungmetastasectomy
AT treasuretom commentonkrasandbrafmutationsareprognosticbiomarkersinpatientsundergoinglungmetastasectomyofcolorectalcancervariationinsurvivalassociatedwithprotooncongenesisnotevidenceforeffectivenessoflungmetastasectomy